Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.
(2010) Circulation — Vol. 122, n° 6, p. 597-602 (2010)
Files
Circ_2010_SD.pdf
Restricted Access - Adobe PDF
- 344.62 KB
Details
- Authors
- Abstract
- The frequency of sudden unexpected death is highest in the early post-myocardial infarction (MI) period; nevertheless, 2 recent trials showed no improvement in mortality with early placement of an implantable cardioverter-defibrillator after MI.
- Affiliations
Citations
Pouleur, A.-C., Barkoudah, E., Uno, H., Skali, H., Finn, P. V., Zelenkofske, S. L., Belenkov, Y. N., Mareev, V., Velazquez, E. J., Rouleau, J. L., Maggioni, A. P., Køber, L., Califf, R. M., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2010). Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation, 122(6), 597-602. https://doi.org/10.1161/CIRCULATIONAHA.110.940619 (Original work published 2010)